PROGNOSTIC-SIGNIFICANCE OF DNA ANEUPLOIDY IN DIFFUSE MALIGNANT MESOTHELIOMA

被引:17
作者
ISOBE, H
SRIDHAR, KS
DORIA, R
COHEN, F
RAUB, WA
SALDANA, M
KRISHAN, A
机构
[1] UNIV MIAMI, SCH MED, DEPT RADIAT ONCOL, DIV EXPTL THERAPEUT, MIAMI, FL USA
[2] UNIV MIAMI, SCH MED, DEPT MED, DIV EXPTL THERAPEUT, MIAMI, FL USA
[3] UNIV MIAMI, SCH MED, DEPT PATHOL, DIV EXPTL THERAPEUT, MIAMI, FL USA
来源
CYTOMETRY | 1995年 / 19卷 / 01期
关键词
PLOIDY; DNA CONTENT; FLOW CYTOMETRY; MESOTHELIOMA;
D O I
10.1002/cyto.990190111
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
DNA ploidy of pepsin digested preparations of 48 paraffin-embedded specimens from 19 patients with histologically confirmed malignant mesothelioma was determined by laser now cytometry. Eight of the 19 tumors (42%) were diploid and 11 (58%) were aneuploid, Of the aneuploid tumors, only one showed multiploidy. The median survival time of the patients with diploid tumors was 19, 16, and 14 months from the onset of symptoms, diagnosis, and treatment, respectively. The median survival in patients with aneuploid tumors was 8, 7, and 7 months from the onset of first symptoms, diagnosis, and treatment, Thus, patients with diploid tumors Lived longer than patients with aneuploid tumors, These results suggest that DNA ploidy analysis may be of prognostic value in malignant mesothelioma. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:86 / 91
页数:6
相关论文
共 35 条
  • [1] AUTOLYSIS IS A POTENTIAL SOURCE OF FALSE ANEUPLOID PEAKS IN FLOW CYTOMETRIC DNA HISTOGRAMS
    ALANEN, KA
    JOENSUU, H
    KLEMI, PJ
    [J]. CYTOMETRY, 1989, 10 (04): : 417 - 425
  • [2] MALIGNANT PLEURAL MESOTHELIOMA - A DISEASE UNAFFECTED BY CURRENT THERAPEUTIC MANEUVERS
    ALBERTS, AS
    FALKSON, G
    GOEDHALS, L
    VOROBIOF, DA
    VANDERMERWE, CA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 527 - 535
  • [3] MALIGNANT MESOTHELIOMA - PROGNOSTIC VARIABLES IN A REGISTRY OF 180 PATIENTS, THE DANA-FARBER-CANCER-INSTITUTE AND BRIGHAM-AND-WOMENS-HOSPITAL EXPERIENCE OVER 2 DECADES, 1965-1985
    ANTMAN, K
    SHEMIN, R
    RYAN, L
    KLEGAR, K
    OSTEEN, R
    HERMAN, T
    LEDERMAN, G
    CORSON, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (01) : 147 - 153
  • [4] Antman KH, 1989, CANCER PRINCIPLES PR, P1399
  • [5] PROGNOSTIC SIGNIFICANCE OF MODAL DNA VALUE AND OTHER FACTORS IN MALIGNANT-TUMORS, BASED ON 1465 CASES
    ATKIN, NB
    KAY, R
    [J]. BRITISH JOURNAL OF CANCER, 1979, 40 (02) : 210 - 221
  • [6] BARLOGIE B, 1983, CANCER RES, V43, P3982
  • [7] FLOW CYTOMETRIC ANALYSIS OF MALIGNANT PLEURAL MESOTHELIOMAS
    BURMER, GC
    RABINOVITCH, PS
    KULANDER, BG
    RUSCH, V
    MCNUTT, MA
    [J]. HUMAN PATHOLOGY, 1989, 20 (08) : 777 - 783
  • [8] PLEUROPNEUMONECTOMY IN MANAGEMENT OF DIFFUSE MALIGNANT MESOTHELIOMA OF PLEURA - EXPERIENCE WITH 29 PATIENTS
    BUTCHART, EG
    ASHCROFT, T
    BARNSLEY, WC
    HOLDEN, MP
    [J]. THORAX, 1976, 31 (01) : 15 - 24
  • [9] DIFFUSE MALIGNANT MESOTHELIOMA - PROSPECTIVE EVALUATION OF 69 PATIENTS
    CHAHINIAN, AP
    PAJAK, TF
    HOLLAND, JF
    NORTON, L
    AMBINDER, RM
    MANDEL, EM
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (06) : 746 - 755
  • [10] DNA ANALYSIS BY FLOW-CYTOMETRY IN MALIGNANT PLEURAL MESOTHELIOMA - RELATIONSHIP TO HISTOLOGY AND SURVIVAL
    DAZZI, H
    THATCHER, N
    HASLETON, PS
    CHATTERJEE, AK
    LAWSON, RAM
    [J]. JOURNAL OF PATHOLOGY, 1990, 162 (01) : 51 - 55